Breathe BioMedical Inc. (BRTH)

Breathe BioMedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022
Cash & Equivalents	1.64	0.55
Short-Term Investments	0.03	0.03
Cash & Cash Equivalents	1.66	0.57
Cash Growth	190.56%	-
Receivables	0.87	0.94
Other Current Assets	0.04	0.04
Total Current Assets	2.57	1.55
Property, Plant & Equipment	1.57	1.82
Goodwill and Intangibles	0.61	-
Total Long-Term Assets	2.18	1.82
Total Assets	4.75	3.37
Accounts Payable	1.77	1.38
Current Debt	0.33	0.16
Total Current Liabilities	2.1	1.53
Long-Term Debt	1.6	1.07
Total Long-Term Liabilities	1.6	1.07
Total Liabilities	3.7	2.61
Total Debt	1.93	1.23
Debt Growth	56.77%	-
Retained Earnings	-23.8	-15.44
Shareholders' Equity	1.05	0.46
Net Cash / Debt	-0.27	-0.66
Working Capital	0.47	0.01

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).